Showing results (31-40 of 3,904) with videos related to

Sort By:
Pageof 391
American Journal of Cancer Research|July 12, 2021
Multi-organ metastasis as destination for breast cancer cells guided by biomechanical architectureQiushi Lin, Xuesong Chen, Fanzheng Meng, et al.
American Journal of Cancer Research|July 12, 2021
A preclinical report of a cobimetinib-inspired novel anticancer small-molecule scaffold of isoflavones, NSC777213, for targeting PI3K/AKT/mTOR/MEK in multiple cancersBashir Lawal, Wen-Cheng Lo, Ntlotlang Mokgautsi, et al.
American Journal of Cancer Research|July 12, 2021
Induction of epithelial-mesenchymal transition (EMT) by hypoxia-induced lncRNA RP11-367G18.1 through regulating the histone 4 lysine 16 acetylation (H4K16Ac) markPei-Hua Peng, Joseph Chieh-Yu Lai, Jeng-Shou Chang, et al.
American Journal of Cancer Research|July 12, 2021
IL-17 signaling pathway plays a key role in laryngeal squamous cell carcinoma with ethnic specificityLi Qi, Wenzhao Bao, Wei Li, et al.
American Journal of Cancer Research|July 12, 2021
Blood-based risk stratification for pre-malignant and symptomatic plasma cell neoplasms to improve patient managementMaría A Vasco-Mogorrón, José A Campillo, Adela Periago, et al.
American Journal of Cancer Research|July 12, 2021
NONO phase separation enhances DNA damage repair by accelerating nuclear EGFR-induced DNA-PK activationXin-Juan Fan, Yun-Long Wang, Wan-Wen Zhao, et al.
American Journal of Cancer Research|July 12, 2021
A heptamethine cyanine dye serves as a potential marker for myeloid-derived suppressor cellsYoung-Suk Cho, Manh-Hung Do, Hien Duong Thanh, et al.
American Journal of Cancer Research|July 12, 2021
Integrative multiplatform-based molecular profiling of human colorectal cancer reveals proteogenomic alterations underlying mitochondrial inactivationWei Zhang, Donge Tang, Liewen Lin, et al.
American Journal of Cancer Research|July 12, 2021
HP1BP3 promotes tumor growth and metastasis by upregulating miR-23a to target TRAF5 in esophageal squamous cell carcinomaMingyi Shang, Li Weng, Shaoqiu Wu, et al.
American Journal of Cancer Research|July 12, 2021
Targeting ERK combined with apatinib may be a promising therapeutic strategy for treating oral squamous cell carcinomaTong-Chao Zhao, Si-Yuan Liang, Zhi-Hang Zhou, et al.
Pageof 391